137 related articles for article (PubMed ID: 18793611)
1. p53 target DDA3 binds ASPP2 and inhibits its stimulation on p53-mediated BAX activation.
Sun WT; Hsieh PC; Chiang ML; Wang MC; Wang FF
Biochem Biophys Res Commun; 2008 Nov; 376(2):395-8. PubMed ID: 18793611
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus core protein interacts with p53-binding protein, 53BP2/Bbp/ASPP2, and inhibits p53-mediated apoptosis.
Cao Y; Hamada T; Matsui T; Date T; Iwabuchi K
Biochem Biophys Res Commun; 2004 Mar; 315(4):788-95. PubMed ID: 14985081
[TBL] [Abstract][Full Text] [Related]
3. The DEAD box protein Ddx42p modulates the function of ASPP2, a stimulator of apoptosis.
Uhlmann-Schiffler H; Kiermayer S; Stahl H
Oncogene; 2009 May; 28(20):2065-73. PubMed ID: 19377511
[TBL] [Abstract][Full Text] [Related]
4. Insights into the structure and protein-protein interactions of the pro-apoptotic protein ASPP2.
Rotem S; Katz C; Friedler A
Biochem Soc Trans; 2007 Nov; 35(Pt 5):966-9. PubMed ID: 17956256
[TBL] [Abstract][Full Text] [Related]
5. p53 downstream target DDA3 is a novel microtubule-associated protein that interacts with end-binding protein EB3 and activates beta-catenin pathway.
Hsieh PC; Chang JC; Sun WT; Hsieh SC; Wang MC; Wang FF
Oncogene; 2007 Jul; 26(34):4928-40. PubMed ID: 17310996
[TBL] [Abstract][Full Text] [Related]
6. Downregulated mRNA expression of ASPP and the hypermethylation of the 5'-untranslated region in cancer cell lines retaining wild-type p53.
Liu ZJ; Lu X; Zhang Y; Zhong S; Gu SZ; Zhang XB; Yang X; Xin HM
FEBS Lett; 2005 Mar; 579(7):1587-90. PubMed ID: 15757645
[TBL] [Abstract][Full Text] [Related]
7. Human DDA3 is an oncoprotein down-regulated by p53 and DNA damage.
Hsieh WJ; Hsieh SC; Chen CC; Wang FF
Biochem Biophys Res Commun; 2008 May; 369(2):567-72. PubMed ID: 18291097
[TBL] [Abstract][Full Text] [Related]
8. The ASPP interaction network: electrostatic differentiation between pro- and anti-apoptotic proteins.
Benyamini H; Friedler A
J Mol Recognit; 2011; 24(2):266-74. PubMed ID: 20623514
[TBL] [Abstract][Full Text] [Related]
9. ARF antagonizes the ability of Miz-1 to inhibit p53-mediated transactivation.
Miao L; Song Z; Jin L; Zhu YM; Wen LP; Wu M
Oncogene; 2010 Feb; 29(5):711-22. PubMed ID: 19901969
[TBL] [Abstract][Full Text] [Related]
10. FHL2 mediates p53-induced transcriptional activation through a direct association with HIPK2.
Lee SW; Kim EJ; Um SJ
Biochem Biophys Res Commun; 2006 Jan; 339(4):1056-62. PubMed ID: 16343438
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel isoform of iASPP and its interaction with p53.
Zhang X; Diao S; Rao Q; Xing H; Liu H; Liao X; Wang M; Wang J
J Mol Biol; 2007 May; 368(4):1162-71. PubMed ID: 17391696
[TBL] [Abstract][Full Text] [Related]
12. Protein phosphatase 1 interacts with p53BP2, a protein which binds to the tumour suppressor p53.
Helps NR; Barker HM; Elledge SJ; Cohen PT
FEBS Lett; 1995 Dec; 377(3):295-300. PubMed ID: 8549741
[TBL] [Abstract][Full Text] [Related]
13. ASPP1 and ASPP2: common activators of p53 family members.
Bergamaschi D; Samuels Y; Jin B; Duraisingham S; Crook T; Lu X
Mol Cell Biol; 2004 Feb; 24(3):1341-50. PubMed ID: 14729977
[TBL] [Abstract][Full Text] [Related]
14. ASPP1 and ASPP2 are new transcriptional targets of E2F.
Fogal V; Kartasheva NN; Trigiante G; Llanos S; Yap D; Vousden KH; Lu X
Cell Death Differ; 2005 Apr; 12(4):369-76. PubMed ID: 15731768
[TBL] [Abstract][Full Text] [Related]
15. The N-terminus of a novel isoform of human iASPP is required for its cytoplasmic localization.
Slee EA; Gillotin S; Bergamaschi D; Royer C; Llanos S; Ali S; Jin B; Trigiante G; Lu X
Oncogene; 2004 Dec; 23(56):9007-16. PubMed ID: 15489900
[TBL] [Abstract][Full Text] [Related]
16. Nuclear EGFR impairs ASPP2-p53 complex-induced apoptosis by inducing SOS1 expression in hepatocellular carcinoma.
Liu K; Jiang T; Ouyang Y; Shi Y; Zang Y; Li N; Lu S; Chen D
Oncotarget; 2015 Jun; 6(18):16507-16. PubMed ID: 25980493
[TBL] [Abstract][Full Text] [Related]
17. Evidence for the interaction of the regulatory protein Ki-1/57 with p53 and its interacting proteins.
Nery FC; Rui E; Kuniyoshi TM; Kobarg J
Biochem Biophys Res Commun; 2006 Mar; 341(3):847-55. PubMed ID: 16455055
[TBL] [Abstract][Full Text] [Related]
18. [Gemin3 inhibits cell apoptosis through suppression of p53 expression].
Guo Y; Zhang XG; Zhao N; Li TR; Li H
Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):810-5. PubMed ID: 22335944
[TBL] [Abstract][Full Text] [Related]
19. Expression of 53BP2 and ASPP2 proteins from TP53BP2 gene by alternative splicing.
Takahashi N; Kobayashi S; Jiang X; Kitagori K; Imai K; Hibi Y; Okamoto T
Biochem Biophys Res Commun; 2004 Mar; 315(2):434-8. PubMed ID: 14766226
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of the novel protein CCDC106 that interacts with p53 and promotes its degradation.
Zhou J; Qiao X; Xiao L; Sun W; Wang L; Li H; Wu Y; Ding X; Hu X; Zhou C; Zhang J
FEBS Lett; 2010 Mar; 584(6):1085-90. PubMed ID: 20159018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
